IDIBAPS takes part in the MELCAYA project

The research institute will coordinate all the activities organized within the project and will participate in every MELCAYA work package. 

Founded in 1996, the Foundation for Clinical Research Barcelona-Institut d’Investigacions Biomédiques August Pi i Sunyer (IDIBAPS) is a biomedical foundation of excellence that addresses the most frequent diseases in our environment. IDIBAPS is part of the CERCA institution and was accredited for the first time as Health Research Institute by Instituto de Salud Carlos III in 2009. More than 2,000 professionals work at IDIBAPS, organized in a hundred of research groups, which seek answers to the questions that arise at the patient’s bedside, so that the advances are quickly transferred to the patients. With more than 1,800 articles published last year, it is the main biomedical research center in Spain.

IDIBAPS is excited to participate in MELCAYA, which is coordinated by Susana Puig, head of the research group Melanoma: imaging, genetics and immunology. Melanoma is currently poorly studied in children and young adults (CAYA) and there are no personalised guidelines. “The MELCAYA project includes experts in different disciplines such as oncology, paediatrics, ethics, policymakers, and more, as well as different sectors, from hospitals to research centres and patient associations, to change this situation and improve the approach taken to melanoma in young people”, Puig explains.

IDIBAPS will coordinate all the activities organized within the project, such as workshops and meetings. Moreover, it will lead work packages 6 and 7, although it will take part in each of the 11 work packages that make up the project.

Work package 6, entitled “Use of minimally and non-invasive technologies for early detection of metastasis and prognosis” will focus on developing an artificial intelligence decision support system to do risk stratification of melanoma patients using clinical, dermatologic and histopathological information. This work package is also aimed at developing diagnostic devices, like a breath analyzer and a disposable skin patch to detect compounds in exhaled breath linked to melanoma.

The goal of work package 7“Health care system strategies implementation to inform policy and ethical dimension” is to provide advice on new healthcare system strategies compliant with European legislation and ethical standards for the prevention and early detection of melanoma in the EU. To do that, an assessment of the current standard of care will be performed, as well as an ethical, legal and social evaluation of the innovative technologies for early diagnosis of melanoma in CAYA.

Author: Marta Pulido on behalf of IDIBAPS


IDIBAPS, MELCAYA, Melanoma, Research, Susana Puig, Diagnostic

Share on Social Media

This project has received funding from the European Health and Digital Executive Agency under grant agreement No 101096667.

Project Office

August Pi i Sunyer Biomedical Research Institute (IDIBAPS)

Campus Casanova, Casanova, 143

08036 Barcelona